PPC
IART icon

Park Place Capital’s Integra LifeSciences IART Stock Holding History

Park Place Capital’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87
Closed -$3.08K – 886
2024
Q1 		$3.08K Buy
+87
New +$3.48K ﹤0.01% 784
2023
Q4 		– Sell
-311
Closed -$11.9K – 942
2023
Q3 		$11.9K Buy
311
+241
+344% +$10.1K ﹤0.01% 730
2023
Q2 		$2.88K Hold
70
– – ﹤0.01% 912
2023
Q1 		$4.02K Hold
70
– – ﹤0.01% 885
2022
Q4 		$4K Buy
+70
New +$3.56K ﹤0.01% 885

Other funds holding IART

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Park Place Capital's IART Position: Q2 2024 in Review

Park Place Capital sold out of Integra LifeSciences (IART) in Q2 2024, closing a stake of 87 shares — an estimated $3.08K sold.

Park Place Capital first reported a position in IART in Q4 2022 and held it in 5 quarters. The position peaked at $11.9K in Q3 2023. 238 funds tracked by Wall St. Rank hold IART as of Q2 2024.

  • Park Place Capital reported no remaining Integra LifeSciences position as of Q2 2024 after selling out during the quarter.
  • Park Place Capital sold 87 Integra LifeSciences shares in Q2 2024, an estimated $3.08K.
  • Park Place Capital first reported a position in Integra LifeSciences in Q4 2022 and held it in 5 quarters.
  • Park Place Capital's Integra LifeSciences position peaked at $11.9K in Q3 2023.
  • 238 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2024.

Based on Park Place Capital's 13F filing for Q2 2024, filed 2 Jul 2024.